ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,864Medicare Part D Prescriptions Filled, Including Refills

Rank: 711 out of 3734

$431K Total Retail Price of All Prescriptions

Rank: 945 out of 3734

462 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 462 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

6% of this provider’s 462 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 8,151 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
OMEPRAZOLE 388 355 1 4
SIMVASTATIN 359 317 2 1
LISINOPRIL 353 312 3 3
LEVOTHYROXINE SODIUM 316 287 4 2
AMLODIPINE BESYLATE 267 228 5 5
PRAVASTATIN SODIUM 257 252 6 15
METOPROLOL TARTRATE 248 242 7 6
FUROSEMIDE 209 207 8 7
POTASSIUM CHLORIDE 196 183 9 19
ATORVASTATIN CALCIUM 194 184 10 11
WARFARIN SODIUM 180 176 11 10
ATENOLOL 176 171 12 13
METOPROLOL SUCCINATE 149 134 13 14
METFORMIN HCL 147 118 14 8
TRAMADOL HCL-ACETAMINOPHEN 129 117 15 191
RANITIDINE HCL 127 113 16 32
ISOSORBIDE MONONITRATE ER 126 126 17 34
HYDROCHLOROTHIAZIDE 124 102 18 9
DIOVAN 118 114 19 31
CLOPIDOGREL 101 89 20 23
KLOR-CON 10 101 99 20 140
AZITHROMYCIN 89 76 22 38
DIGOXIN 89 87 22 43
CITALOPRAM HBR 88 84 24 16
KLOR-CON M10 81 80 25 115
DONEPEZIL HCL 78 78 26 25
CRESTOR 78 76 26 28
PLAVIX 77 70 28 39
HYDROCODONE-ACETAMINOPHEN 76 61 S3 29 12
BUMETANIDE 75 75 30 78
ALLOPURINOL 72 72 31 33
CARVEDILOL 71 66 32 30
SYNTHROID 68 68 33 47
SERTRALINE HCL 68 52 33 18
NEXIUM 67 56 35 36
NAMENDA 67 67 35 44
FLUTICASONE PROPIONATE 65 63 37 46
TERAZOSIN HCL 65 65 37 136
ALENDRONATE SODIUM 63 63 39 26
PREDNISONE 61 54 40 42
PANTOPRAZOLE SODIUM 57 54 41 22
ZOLPIDEM TARTRATE 56 49 42 24
GABAPENTIN 54 52 43 17
ESCITALOPRAM OXALATE 54 50 43 68
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 3, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.